Add BrightSurf on Google Email

Novocure reports data showing TTF therapy in combination with chemotherapy has the potential to increase overall survival for patients with advanced non-small cell lung cancer

In a phase II study, patients with locally advanced and metastatic NSCLC experienced significant increases in survival time when treated with TTF therapy in combination with chemotherapy. The therapy has also been shown to have clinical efficacy in human trials for other solid tumors, including recurrent glioblastoma.

Well-tolerated radiotherapy provides longer life to patients with recurrent brain cancer

Researchers at Thomas Jefferson University found that hypofractionated stereotactic radiotherapy significantly improves survival rates for patients with recurrent brain cancers, while minimizing side effects. The treatment provides longer survival without experiencing common chemotherapy and targeted therapy side effects.

SourceThomas Jefferson University·JournalJournal of Clinical Oncology·DateMay 17, 2010

Viruses against cancer

Researchers have found that parvoviruses can completely regress malignant brain tumors in rats and human gliomas. The viruses target cancer cells without affecting healthy tissue, making them a potential new approach to treating glioblastoma.

SourceHelmholtz Association·JournalNeuro-Oncology·DateMay 4, 2010

Brain cancer: Study focuses on forgotten cells

Scientists have discovered that residual glioblastoma cells have different properties than those found in the tumor mass, making them more mobile and resistant to treatment. This breakthrough could lead to new therapeutic approaches against this aggressive brain cancer.

SourceUniversity of Bonn·JournalAnnals of Neurology·DateApr 13, 2010

Researchers quantify benefits of minimally invasive removal of hard-to-reach tumors

Researchers have developed a minimally invasive endoscopic procedure that can safely remove large brain tumors from an area at the bottom of the skull, near the sinus cavities. The study found that this approach resulted in complete tumor removal in 96% of patients and could be a game-changer for patients with pituitary macroadenomas.

SourceUniversity of Cincinnati·JournalJournal of Neurosurgery·DateApr 1, 2010

Articles highlight challenges, progress in nervous system cancers

Recent clinical and scientific advancements in nervous system cancers have improved our understanding of molecular changes and new therapies for patients. The March issue of Archives of Neurology features articles on various topics, including increased melanoma risk among Parkinson's disease patients and new insights into glioma risk.

SourceJAMA Network·JournalArchives of Neurology·DateMar 8, 2010

JCI table of contents: Feb. 22, 2010

Researchers at Stanford University School of Medicine have found that disrupting the SDF-1/CXCR4 interaction can prevent the recruitment of vasculogenic cells to the tumor site, blocking postirradiation development of functional tumor vasculature and tumor regrowth. This approach may be applicable to treating glioblastoma multiforme.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 22, 2010

Selective brain damage modulates human spirituality

Research finds that selective brain damage, particularly in parietal regions, can modulate human spirituality and religious attitudes. The study identified a causative link between specific brain lesions and changes in self-transcendence, a personality trait reflecting spiritual feeling and behavior.

SourceCell Press·JournalNeuron·DateFeb 10, 2010

No change in brain tumor incidence during a time when cell phone usage increased

A recent study published in the Journal of the National Cancer Institute found no significant link between increased cell phone usage and brain tumor incidence. The research analyzed data from Denmark, Finland, Norway, and Sweden over a 30-year period, concluding that induction periods may be longer than previously thought.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateDec 3, 2009

Addition of whole-brain radiation therapy to standard radiosurgery results in worse learning and memory function for patients with brain tumors

Patients with brain tumors treated with WBRT plus SRS experience significant decline in learning and memory function compared to those receiving SRS alone. The study concludes that SRS alone combined with close clinical monitoring is the preferred treatment strategy for patients newly diagnosed with one to three brain metastases.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateOct 4, 2009